170 related articles for article (PubMed ID: 8070008)
1. Synergistic effect of inhibitors of topoisomerase I and II on chromosome damage and cell killing in cultured Chinese hamster ovary cells.
Cortés F; Piñero J
Cancer Chemother Pharmacol; 1994; 34(5):411-5. PubMed ID: 8070008
[TBL] [Abstract][Full Text] [Related]
2. Importance of replication fork progression for the induction of chromosome damage and SCE by inhibitors of DNA topoisomerases.
Cortés F; Piñero J; Ortiz T
Mutat Res; 1993 Oct; 303(2):71-6. PubMed ID: 7692280
[TBL] [Abstract][Full Text] [Related]
3. Enhanced sensitivity to topoisomerase inhibitors in synchronous CHO cells pre-treated with 5-azacytidine.
López-Baena M; Mateos S; Piñero J; Trinidad Ortiz ; Cortés F
Mutat Res; 1998 Oct; 421(1):109-16. PubMed ID: 9748527
[TBL] [Abstract][Full Text] [Related]
4. Sister chromatid exchanges, chromosomal aberrations, and cytotoxicity produced by antitumor topoisomerase II inhibitors in sensitive (DC3F) and resistant (DC3F/9-OHE) Chinese hamster cells.
Pommier Y; Kerrigan D; Covey JM; Kao-Shan CS; Whang-Peng J
Cancer Res; 1988 Feb; 48(3):512-6. PubMed ID: 2825977
[TBL] [Abstract][Full Text] [Related]
5. Cytogenetical characterization of Chinese hamster ovary X-ray-sensitive mutant cells, xrs 5 and xrs 6. IV. Study of chromosomal aberrations and sister-chromatid exchanges by restriction endonucleases and inhibitors of DNA topoisomerase II.
Darroudi F; Natarajan AT
Mutat Res; 1989 Jun; 212(2):137-48. PubMed ID: 2543922
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of replicon initiation in human cells following stabilization of topoisomerase-DNA cleavable complexes.
Kaufmann WK; Boyer JC; Estabrooks LL; Wilson SJ
Mol Cell Biol; 1991 Jul; 11(7):3711-8. PubMed ID: 1646393
[TBL] [Abstract][Full Text] [Related]
7. Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons.
D'Arpa P; Beardmore C; Liu LF
Cancer Res; 1990 Nov; 50(21):6919-24. PubMed ID: 1698546
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetic effects of inhibition of topoisomerase I or II activities in the CHO mutant EM9 and its parental line AA8.
Cortés F; Piñero J; Palitti F
Mutat Res; 1993 Aug; 288(2):281-9. PubMed ID: 7688089
[TBL] [Abstract][Full Text] [Related]
9. Sister chromatid exchange induced by DNA topoisomerases poisons in late replicating heterochromatin: influence of inhibition of replication and transcription.
Piñero J; López Baena M; Ortiz T; Cortés F
Mutat Res; 1996 Jul; 354(2):195-201. PubMed ID: 8764948
[TBL] [Abstract][Full Text] [Related]
10. Cell cycle dependence of sister chromatid exchange induction by DNA topoisomerase II inhibitors in Chinese hamster V79 cells.
Dillehay LE; Denstman SC; Williams JR
Cancer Res; 1987 Jan; 47(1):206-9. PubMed ID: 3024815
[TBL] [Abstract][Full Text] [Related]
11. Aurintricarboxylic acid, a putative inhibitor of apoptosis, is a potent inhibitor of DNA topoisomerase II in vitro and in Chinese hamster fibrosarcoma cells.
Benchokroun Y; Couprie J; Larsen AK
Biochem Pharmacol; 1995 Jan; 49(3):305-13. PubMed ID: 7857317
[TBL] [Abstract][Full Text] [Related]
12. Correlations between intercalator-induced DNA strand breaks and sister chromatid exchanges, mutations, and cytotoxicity in Chinese hamster cells.
Pommier Y; Zwelling LA; Kao-Shan CS; Whang-Peng J; Bradley MO
Cancer Res; 1985 Jul; 45(7):3143-9. PubMed ID: 2988762
[TBL] [Abstract][Full Text] [Related]
13. The concentration-dependent diversity of effects of DNA topoisomerase I and II inhibitors on the cell cycle of HL-60 cells.
Del Bino G; Skierski JS; Darzynkiewicz Z
Exp Cell Res; 1991 Aug; 195(2):485-91. PubMed ID: 1649059
[TBL] [Abstract][Full Text] [Related]
14. Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in Chinese hamster DC3F cells.
Holm C; Covey JM; Kerrigan D; Pommier Y
Cancer Res; 1989 Nov; 49(22):6365-8. PubMed ID: 2553254
[TBL] [Abstract][Full Text] [Related]
15. Antagonism between camptothecin and topoisomerase II-directed chemotherapeutic agents in a human leukemia cell line.
Kaufmann SH
Cancer Res; 1991 Feb; 51(4):1129-36. PubMed ID: 1705167
[TBL] [Abstract][Full Text] [Related]
16. A human small cell lung carcinoma cell line, resistant to 4'-(9-acridinylamino)-methanesulfon-m-anisidide and cross-resistant to camptothecin with a high level of topoisomerase I.
Prost S; Riou G
Biochem Pharmacol; 1994 Aug; 48(5):975-84. PubMed ID: 8093110
[TBL] [Abstract][Full Text] [Related]
17. Differential induction of chromosomal aberrations by topoisomerase inhibitors in cultured Chinese hamster cells.
Suzuki H; Nakane S
Biol Pharm Bull; 1994 Feb; 17(2):222-6. PubMed ID: 8205120
[TBL] [Abstract][Full Text] [Related]
18. DNA double-strand break repair pathways and cellular tolerance to inhibitors of topoisomerase II.
Caldecott K; Banks G; Jeggo P
Cancer Res; 1990 Sep; 50(18):5778-83. PubMed ID: 2168280
[TBL] [Abstract][Full Text] [Related]
19. Genotoxicity of inhibitors of DNA topoisomerases I (camptothecin) and II (m-AMSA) in vivo and in vitro.
Backer LC; Allen JW; Harrington-Brock K; Campbell JA; DeMarini DM; Doerr CL; Howard DR; Kligerman AD; Moore MM
Mutagenesis; 1990 Nov; 5(6):541-7. PubMed ID: 2175833
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of topoisomerase I and II inhibitors cell killing by tumor necrosis factor: relationship to DNA strand breakage formation.
Orengo G; Noviello E; Cimoli G; Pagnan G; Parodi S; Venturini M; Conte P; Schenone F; Conzi G; Russo P
Jpn J Cancer Res; 1992 Nov; 83(11):1132-6. PubMed ID: 1336489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
